Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

• Үндсэн зохиолчид: Lukas Buendgens (Зохиогч), Eray Yagmur (Зохиогч), Axel Ginsberg (Зохиогч), Ralf Weiskirchen (Зохиогч), Theresa Wirtz (Зохиогч), Samira Abu Jhaisha (Зохиогч), Albrecht Eisert (Зохиогч), Tom Luedde (Зохиогч), Christian Trautwein (Зохиогч), Frank Tacke (Зохиогч), Alexander Koch (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Hindawi Limited, 2020-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Adrenomedullin (ADM) is a peptide with pleiotropic effects in systemic inflammation. Its more stable precursor protein midregional proadrenomedullin (MRproADM) can be measured more reliably compared to ADM. Our objective was to investigate the potential role of MRproADM as a diagnostic and prognosti...